Colgate-Palmolive Company $CL Shares Sold by Saratoga Research & Investment Management

Saratoga Research & Investment Management lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 186,563 shares of the company’s stock after selling 7,532 shares during the quarter. Colgate-Palmolive comprises about 0.8% of Saratoga Research & Investment Management’s holdings, making the stock its 28th biggest holding. Saratoga Research & Investment Management’s holdings in Colgate-Palmolive were worth $14,742,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Maseco LLP acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $27,000. Copia Wealth Management acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $29,000. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $30,000. Global Wealth Strategies & Associates raised its holdings in Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares in the last quarter. Finally, Grove Bank & Trust raised its holdings in Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Zacks also highlighted Colgate’s innovation strategy as a support for market share gains, with premium launches, pricing actions and science-based products helping growth in oral care and pet nutrition. Why Colgate’s Innovation Strategy Is Fueling Market Share Gains
• Neutral Sentiment: Analysts lowered near-term and longer-term EPS estimates, but the changes were relatively modest and the new forecasts still point to continued earnings growth over the next few years.
• Negative Sentiment: Zacks Research cut FY2026 EPS to $3.80 from $3.89, FY2027 to $4.01 from $4.15, FY2028 to $4.39 from $4.44, and reduced several quarterly estimates, signaling a slightly less optimistic profit outlook for Colgate-Palmolive. Analyst estimate cuts for Colgate-Palmolive

Wall Street Analysts Forecast Growth

CL has been the topic of several analyst reports. UBS Group raised their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Weiss Ratings raised shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Finally, Evercore raised their target price on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Twelve research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $88.20 on Friday. The firm’s fifty day simple moving average is $86.30 and its 200-day simple moving average is $84.68. The stock has a market capitalization of $70.76 billion, a price-to-earnings ratio of 34.32, a PEG ratio of 4.57 and a beta of 0.31. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.91 EPS. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.